Pfizer Inc.


Pfizer’s shares are down 45% in the past year due to lower demand for its COVID-19 treatments as the pandemic eases. However, new products from its acquisition of Seagen and its high research spending, generally, should spur long-term growth and your dividends.


PFIZER INC....
PFIZER INC., $26.63, New York symbol PFE, remains a buy for long-term gains.

The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).

Pfizer has now completed its acquisition of Seagen Inc....
MCDONALD’S CORP., $285.52, New York symbol MCD, is your #1 Conservative Buy for 2023.

The company is the world’s largest fast-food chain with over 40,000 restaurants in 119 countries. It serves a wide variety of food but is best known for its hamburgers and french fries.

McDonald’s shares have gained over 50% in the past five years....
STANLEY BLACK & DECKER INC. $90 (www.stanleyblackanddecker.com) is a buy. The company is one of the world’s largest makers of hand and power tools....
PROCTER & GAMBLE CO., $147.16, New York symbol PG, is a top pick for 2023.

The company is one of the world’s largest makers of household and personal-care goods. Major brands include Tide (laundry detergent), Pampers (diapers), Gillette (razors), Crest (toothpaste) and Vicks (cold remedies).

Procter has paid shareholder dividends for 133 years and has increased its payout annually for the past 67 years....
Pfizer recently cut its outlook for 2023 due to declining demand for its COVID-19 vaccines and treatments. However, the company is using the huge profits it earned on those products to buy other drugmakers with promising products.


We feel these moves, as well as Pfizer’s own highly successful research efforts, set it up for many more years of rising sales and earnings....
PFIZER INC., $30.63, New York symbol PFE, remains a buy.

The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).

Due to slowing demand for its COVID-19 products—Comirnaty (vaccine) and Paxlovid (antiviral pill)—Pfizer now expects its sales for all of 2023 will range between $58.0 billion and $61.0 billion....

In the past few years, big pharmaceutical companies have spun off their consumer drug operations. That’s part of their strategy to focus on more-profitable prescription drug businesses. These two recent spinoffs have decent long-term prospects, but their shares will likely remain depressed until they cut their high debt loads.


VIATRIS INC....
BANK OF MONTREAL, $114.19, Toronto symbol BMO, is a buy.

With the August 2023 payment, Bank of Montreal raised your quarterly dividend by 2.8%, to $1.47 a share from $1.43. The new annual rate of $5.88 yields a high 5.1%.

On February 1, 2023, the bank completed its acquisition of Bank of the West from France’s BNP Paribas.

Bank of the West provides a variety of retail and commercial banking services to over 1.8 million customers in 24 U.S....
VERIZON COMMUNICATIONS INC., $33.45, New York symbol VZ, is your #1 Income Buy for 2023.

The telecom provider is the second-largest wireless carrier in the U.S. after AT&T (New York symbol T), with 143.2 million subscribers (consumers and businesses) as of June 30, 2023....